Journal
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
Volume 2021, Issue 20, Pages 1921-1928Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/ejic.202100120
Keywords
Alkynyl ligands; Cytotoxicity; Gold; Thioredoxin reductase; Translocator proteins
Categories
Funding
- European Union's Horizon 2020 research and innovation programme (H2020-MSCA-IF-2016) [REP-749621-1]
- National Cancer Institute [P30 CA071789]
- IReL
- B.H. and Alice C. Beams Endowed Professorship in Cancer Research
Ask authors/readers for more resources
A series of gold(I) complexes were synthesized and characterized, with two of them showing cytotoxic effects in bladder cancer cells by inducing reactive oxygen species and caspase-mediated apoptosis. These complexes also inhibit thioredoxin reductase, a known target of anticancer gold(I) complexes, suggesting a potential mechanism of action for their anticancer effects.
A series of gold(I) complexes with the general formula [Au(L2)(L ')] (L2=4-phenyl-N-(prop-2-yn-1-yl)quinazoline-2-carboxamide, L '=PPh3 (triphenylphosphine), 1; TPA (1,3,5-triaza-7-phosphaadamantane), 2, and Me-2-imy (1,3-dimethylimidazol-2-ylidene), 3) were synthesized and fully characterized by spectroscopic methods. The alkynyl ligand L2 belongs to the quinazoline carboxamide class of ligands that are known to bind to the translocator protein (TSPO) at the outer mitochondrial membrane. 1 and 2 exert cytotoxic effects in bladder cancer cells with IC50 values in the low micromolar range. Further mechanistic analysis indicated that the two complexes both act by inducing reactive oxygen species and caspase-mediated apoptosis. The complexes inhibit thioredoxin reductase, an established target of anticancer gold(I) complexes. Docking studies confirmed that after ligand exchange the free ligand L2 can interact with the TSPO binding site.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available